International stocks trading in New York closed higher Thursday,
with the Bank of New York index of American depositary receipts
rose 0.5% to 150.39. The European index added 0.7% to 151.16, the
Asian index was essentially flat at 143.84, the Latin American
index rose 0.6% to 257.83 and the emerging markets index climbed
0.5% to 263.03. Among the companies with shares that actively
traded were Gol Linhas Aereas Inteligentes SA (GOL, GOLL4.BR).
Air France-KLM (AFLYY, AF.FR) announced plans to buy a small
stake in Gol, paying a steep premium to cement a broader alliance
with Brazil's second-largest airline by traffic. The European
carrier would inject $100 million into loss-making Gol, taking a
nonvoting stake alongside fellow SkyTeam alliance member Delta Air
Lines Inc. (DAL), which bought into the Brazilian carrier two years
ago. Gol shares rose 7.9% to $4.91.
Deutsche Bank AG (DB, DBK.XE) reached an agreement to settle a
12-year legal battle with the heirs of late media mogul Leo Kirch,
chipping away further at a backload of pending litigation that has
weighed on Germany's largest bank's outlook. Shares were
essentially flat at $48.33.
U.K. drug company GlaxoSmithKline PLC (GSK, GSK.LN) and
Theravance, Inc. (THRX) said a European Union agency recommended
that their new treatment for lung disease be approved for sale. The
European Medicines Agency's Committee for Medicinal Products for
Human Use recommended marketing authorization for Anoro, a drug for
people with chronic obstructive pulmonary disease, or COPD,
GlaxoSmithKline said in a statement with San Francisco-based
Theravance. GlaxoSmithKline shares rose 0.9% to 56.22.
Write to Anna Prior at anna.prior@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires